Imbruvica (ibrutinib)

pCPA File Number: 20856
Negotiation Status:
Negotiations were not pursued
Indication(s):
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sponsor/Manufacturer:
Janssen Inc.
CADTH Project Number:
pCODR 10082
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: